Early Symptomatic Alzheimer’s Disease (eAD), (Mild Cognitive Impairment due to AD, or probable AD dementia)
Conditions
Interventions
None listed
Sponsors
F. Hoffmann-La Roche AG
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Countries
Netherlands, Poland, Spain, Sweden
Outcome results
None listed